|
|
10400 Viking Drive, Suite 100 Eden Prairie, MN 55344 phone:952-937-7660 fax:952-937-7667
|
|
| Symbol |
Private |
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.humaneticscorp.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Specialty pharmaceuticals orally-administered, bioactive compounds. |
 |
| Management |
| Ronald J. Zenk, is the Founder, Chief Executive Officer, President, and a Director of Humanetics; John C. Dykstra, is Chief Operating Officer and a Director of Humanetics; James R. Behnke, PhD., is currently a new business development; Duane S. Carlson, is currently an independent management consultant; Theodore A. Johnson, is currently an independent management consultant; General Richard I. Neal, is currently serving as President of Audio MPEG |
| |
|
|
| |
|
| Keywords |
| immunodeficiency disorders, neurodegenerative diseases and metabolic dysfunction |
|
|
|
| Description |
|
Humanetics Corporation is a specialty pharmaceutical company focused on rapid discovery, development and commercialization of proprietary, orally-administered, bioactive compounds for disease prevention and treatment. |
 |
| Technology / Differentiation |
| Humanetics has an extensive patent portfolio and an active pipeline of compounds that range from discovery phase to human clinical trials. |
 |
| Market / Customers |
Company is focused on three biotherapeutic areas with urgent and unmet needs: immunodeficiency disorders, neurodegenerative diseases and metabolic dysfunction.
|
 |
|
|
|
|
|
|